Assembly Biosciences, Inc. (ASMB) NASDAQ

14.15

+0.3399(+2.46%)

Updated at February 05 12:59PM

Currency In USD

Valuation

Market Cap45.04M
Enterprise Value27.54M
P/E Ratio-2.2
PEG Ratio-0.11
Price/Sales Ratio3.18
Price/Book Ratio3.46
Enterprise/Revenue2.22
Enterprise/EBITDA-1.36

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-1.44
Operating Margin-1.64

Management Effectiveness

Return On Assets-0.41
Return On Equity-1.21

Income Statement

Revenue7.16M
Revenue/Share4.46
Gross Profit-41.74M
EBITDA-64.2M
Net Income-61.23M
Diluted EPS-13.38

Balance Sheet

Total Cash94.95M
Total Cash/Share14.95
Total Debt1.44M
Total Debt/Equity0.06
Current Ratio2.36
Book Value Per Share4.09

Price History

52-Week Change16.75
52-Week High19.93
52-Week Low9.84
Moving Average 50 Days15.39
Moving Average 200 Days15.25

Statistics

Average Volume33,347
Shares Outstanding6.36M
% Held by Institutions0.01

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateFebruary 12, 2024